Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis
- PMID: 30790016
- DOI: 10.1007/s00296-019-04255-2
Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis
Abstract
The objective was to investigate the clinical and histological features of liver dysfunction in patients with polymyositis (PM) or dermatomyositis (DM).A total of 115 patients (38 with PM and 77 with DM), who were admitted to our hospital between 2001 and 2012, were retrospectively reviewed. Liver dysfunction was defined as an alanine transaminase (ALT) level ≥ 60 U/l and a disproportionate ALT elevation relative to the creatine kinase level. The histological findings from liver biopsies were also assessed.The frequencies of liver dysfunction were 3% and 17% in the patients with PM and DM, respectively. Liver dysfunction was not observed in the patients who had malignancies. Among the patients with DM with no malignancies (n = 50), 20% had liver dysfunction, and all of the patients with liver dysfunction were positive for the anti-melanoma differentiation-associated gene 5 (MDA5) antibody. Compared with those in the patients who did not have liver dysfunction, the ALT, alkaline phosphatase, γ-glutamyl transferase, and KL-6 levels were significantly elevated in the patients who had liver dysfunction. Six patients, comprising four with DM and two with PM, underwent liver biopsies, and the common histological findings associated with DM were steatosis, hepatocyte ballooning, increases in the pigmented macrophage numbers, and glycogenated nuclei. Hemophagocytosis was detected in two of three patients with DM who underwent liver biopsies and bone marrow aspirations. In conclusion, Liver dysfunction might be an extramuscular manifestation in patients with DM who are anti-MDA5 antibody-positive. Steatosis and hepatocyte ballooning could be common histological features.
Keywords: Fatty liver; Macrophage activation syndrome; Non-alcoholic fatty liver disease; Skin ulcer.
Similar articles
-
Anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis with liver dysfunction: a warning sign of higher death risk.Clin Rheumatol. 2024 Nov;43(11):3389-3397. doi: 10.1007/s10067-024-07093-1. Epub 2024 Sep 17. Clin Rheumatol. 2024. PMID: 39287702
-
Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.Respir Med. 2016 Dec;121:91-99. doi: 10.1016/j.rmed.2016.10.019. Epub 2016 Nov 2. Respir Med. 2016. PMID: 27888997
-
Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.PLoS One. 2016 Apr 26;11(4):e0154285. doi: 10.1371/journal.pone.0154285. eCollection 2016. PLoS One. 2016. PMID: 27115353 Free PMC article.
-
Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.Arthritis Care Res (Hoboken). 2013 Aug;65(8):1316-24. doi: 10.1002/acr.21985. Arthritis Care Res (Hoboken). 2013. PMID: 23908005 Review.
-
[Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].Zhonghua Er Ke Za Zhi. 2019 Dec 2;57(12):928-933. doi: 10.3760/cma.j.issn.0578-1310.2019.12.007. Zhonghua Er Ke Za Zhi. 2019. PMID: 31795559 Review. Chinese.
Cited by
-
Anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis with liver dysfunction: a warning sign of higher death risk.Clin Rheumatol. 2024 Nov;43(11):3389-3397. doi: 10.1007/s10067-024-07093-1. Epub 2024 Sep 17. Clin Rheumatol. 2024. PMID: 39287702
-
Liver Involvement is Associated with Higher Risk of Rapidly Progressive Interstitial Lung Disease and Mortality in Anti-Melanoma Differentiation-Associated Gene 5 Antibody- Positive Dermatomyositis.J Inflamm Res. 2024 May 17;17:3101-3113. doi: 10.2147/JIR.S462721. eCollection 2024. J Inflamm Res. 2024. PMID: 38774443 Free PMC article.
-
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies.Front Immunol. 2021 Oct 20;12:773352. doi: 10.3389/fimmu.2021.773352. eCollection 2021. Front Immunol. 2021. PMID: 34745149 Free PMC article. Review.
-
Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis.Clin Rheumatol. 2020 Jun;39(6):1919-1927. doi: 10.1007/s10067-019-04918-2. Epub 2020 Jan 15. Clin Rheumatol. 2020. PMID: 31942657
-
Cyclophosphamide-induced liver injury during treatment of interstitial lung disease in juvenile dermatomyositis.BMJ Case Rep. 2023 Aug 9;16(8):e252592. doi: 10.1136/bcr-2022-252592. BMJ Case Rep. 2023. PMID: 37558279
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous